Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-12-30 4:12 pm Purchase |
2022-12-22 | 13G | Iovance Biotherapeutics, Inc. IOVA |
MHR FUND MANAGEMENT LLC | 12,083,951 6.700% |
12,083,951 (New Position) |
Filing History |
| 2022-02-24 5:23 pm Sale |
2021-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA |
BLACKROCK INC BLK |
7,408,505 4.700% |
-1,594,083 (-17.71%) |
Filing History |
| 2022-02-14 3:48 pm Purchase |
2021-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA |
PERCEPTIVE ADVISORS LLC | 10,127,941 6.500% |
961,637 (+10.49%) |
Filing History |
| 2022-02-14 2:34 pm Sale |
2021-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA |
PRICE T ROWE ASSOCIATES INC | 4,663,785 2.900% |
-2,718,420 (-36.82%) |
Filing History |
| 2022-02-11 10:04 am Purchase |
2021-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA |
AVORO CAPITAL ADVISORS LLC | 8,675,000 5.500% |
1,175,000 (+15.67%) |
Filing History |
| 2022-02-10 08:17 am Purchase |
2021-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA |
The Vanguard Group | 12,197,787 7.770% |
332,405 (+2.80%) |
Filing History |
| 2022-02-04 2:25 pm Sale |
2021-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA |
FRANKLIN RESOURCES INC BEN |
5,797,716 3.700% |
-3,131,188 (-35.07%) |
Filing History |
| 2022-02-04 09:27 am Purchase |
2021-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA |
WELLINGTON MANAGEMENT CO LLP | 9,584,082 6.110% |
9,584,082 (New Position) |
Filing History |
| 2021-02-16 3:33 pm Sale |
2020-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA |
PERCEPTIVE ADVISORS LLC | 9,166,304 6.300% |
-245,092 (-2.60%) |
Filing History |
| 2021-02-16 12:23 pm Purchase |
2020-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA |
PRICE T ROWE ASSOCIATES INC | 7,382,205 5.000% |
872,349 (+13.40%) |
Filing History |
| 2021-02-12 08:03 am Sale |
2020-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA |
AVORO CAPITAL ADVISORS LLC | 7,500,000 5.100% |
-1,326,039 (-15.02%) |
Filing History |
| 2021-02-10 11:10 am Purchase |
2020-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA |
The Vanguard Group | 11,865,382 8.090% |
1,012,253 (+9.33%) |
Filing History |
| 2021-02-01 5:05 pm Purchase |
2020-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA |
FRANKLIN RESOURCES INC BEN |
8,928,904 6.100% |
3,451,148 (+63.00%) |
Filing History |
| 2021-01-29 09:57 am Sale |
2020-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA |
BLACKROCK INC BLK |
9,002,588 6.100% |
-592,072 (-6.17%) |
Filing History |
| 2021-01-11 2:21 pm Purchase |
2020-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA |
ARK Investment Management LLC | 15,297,822 10.430% |
15,297,822 (New Position) |
Filing History |